Evidence method
Level · gp.fundamentals.debt_to_revenue
174.47% · OPTIONAL · VALID
GROSSPATTERN / FUNDAMENTAL STATE / POINT IN TIME
HBIO · Mar 31, 2026
HARVARD BIOSCIENCE INC. A multidimensional configuration derived from the filing available at this observation—never a composite score or recommendation.
STATE CAPABILITYLEVEL 3[email protected]
Inspectable configuration
State dimensions
Filing0001171843-26-003311General Corporate
Evidence method
Level · gp.fundamentals.capex_revenue_ratio
2.05% · OPTIONAL · VALID
Evidence method
Ratio · gp.fundamentals.operating_cash_flow + gp.fundamentals.revenue
-3.19% · OPTIONAL · VALID
Evidence method
Yoy · gp.fundamentals.revenue
-4.68% · CORE · VALID
Evidence method
Level · gp.fundamentals.inventory_revenue_ratio
106.99% · OPTIONAL · VALID
Evidence method
Level · gp.fundamentals.gross_margin
58.99% · CORE · VALID
Evidence method
Level · gp.fundamentals.operating_margin
-5.66% · CORE · VALID
Evidence method
Ratio · gp.fundamentals.rnd + gp.fundamentals.revenue
11.21% · OPTIONAL · VALID
Evidence method
Level · gp.fundamentals.sbc_revenue_ratio
1.24% · OPTIONAL · VALID
As-filed lineage
Fundamental state history
Each observation is tied to the filing and facts available at that report date. Amendments remain separate.
History16 statesHistory building
Sep 30, 20220/8 normalizedLevel 3Dec 31, 20220/8 normalizedLevel 3Mar 31, 20230/8 normalizedLevel 3Jun 30, 20230/8 normalizedLevel 3Sep 30, 20230/9 normalizedLevel 3Dec 31, 20230/9 normalizedLevel 3Mar 31, 20240/9 normalizedLevel 3Jun 30, 20240/9 normalizedLevel 3Sep 30, 20248/9 normalizedLevel 3Dec 31, 20248/9 normalizedLevel 3Mar 31, 20258/9 normalizedLevel 3Jun 30, 20258/9 normalizedLevel 3Sep 30, 20259/9 normalizedLevel 3Dec 31, 20259/9 normalizedLevel 3Mar 31, 20269/9 normalizedLevel 3Jun 30, 20269/9 normalizedLevel 3
Period transition
What moved in the state?
- Previous
- 41.44%
- Current
- 174.47%
- Delta
- 133.02%
- Previous
- 1.45%
- Current
- 2.05%
- Delta
- 0.60%
- Previous
- 7.77%
- Current
- -3.19%
- Delta
- -10.96%
- Previous
- -8.06%
- Current
- -4.68%
- Delta
- 3.38%
- Previous
- 24.04%
- Current
- 106.99%
- Delta
- 82.95%
- Previous
- 57.67%
- Current
- 58.99%
- Delta
- 1.33%
- Previous
- -56.13%
- Current
- -5.66%
- Delta
- 50.47%
- Previous
- 10.20%
- Current
- 11.21%
- Delta
- 1.01%
- Previous
- 2.14%
- Current
- 1.24%
- Delta
- -0.91%
Self-history only
Previous similar states
Similarity compares compatible valid dimensions from this issuer's own point-in-time history. No market-return claim is attached.
Not enough compatible prior states for a transparent self-history match.
Research Graph
Related governed research
Transitioned To · HBIO Fundamental State →Has State · HARVARD BIOSCIENCE INC →Transitioned To · HBIO Fundamental State →Transitioned To · HBIO BALANCE_SHEET_LEVERAGE_INCREASED →Transitioned To · HBIO CAPEX_INTENSITY_INCREASED →Transitioned To · HBIO CASH_GENERATION_DECREASED →Transitioned To · HBIO GROWTH_INCREASED →Transitioned To · HBIO INVENTORY_PRESSURE_INCREASED →Transitioned To · HBIO MARGIN_INCREASED →Transitioned To · HBIO PROFITABILITY_INCREASED →Transitioned To · HBIO R_AND_D_INTENSITY_INCREASED →Transitioned To · HBIO SBC_INTENSITY_DECREASED →
Method Percentiles and historical matches use only observations available at each point in time. Missing dimensions remain missing. Public price outcomes and cross-market analogues are deliberately absent.